[Federal Register Volume 76, Number 227 (Friday, November 25, 2011)]
[Notices]
[Page 72710]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-30326]
[[Page 72710]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0231]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Adverse Experience Reporting for
Licensed Biological Products; and General Records
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Adverse Experience Reporting for
Licensed Biological Products; and General Records'' has been approved
by the Office of Management and Budget (OMB) under the Paperwork
Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Information
Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B,
Rockville, MD 20850, (301) 796-7726, [email protected].
SUPPLEMENTARY INFORMATION: On July 19, 2011, the Agency submitted a
proposed collection of information entitled ``Adverse Experience
Reporting for Licensed Biological Products; and General Records'' to
OMB for review and clearance under 44 U.S.C. 3507. An Agency may not
conduct or sponsor, and a person is not required to respond to, a
collection of information unless it displays a currently valid OMB
control number. OMB has now approved the information collection and has
assigned OMB control number 0910-0308. The approval expires on November
30, 2014. A copy of the supporting statement for this information
collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain.
Dated: November 18, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-30326 Filed 11-23-11; 8:45 am]
BILLING CODE 4160-01-P